Jeff Cohen
Stock Analyst at Ladenburg Thalmann
(3.35)
# 398
Out of 5,218 analysts
21
Total ratings
80.00%
Success rate
47.00%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Bionano Genomics | Downgrades: Neutral | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
Legacy Education | Initiates Coverage On: Buy | 9 | 8.86 | -7.45% | 1 | Oct 22, 2024 | |
Sonoma Pharmaceutica... | Initiates Coverage On: Buy | 65 | 2.65 | 2352.83% | 1 | Sep 5, 2023 | |
Healthcare Capital | Initiates Coverage On: Buy | 18 | n/a | n/a | 1 | Jan 24, 2022 | |
DraftKings | Initiates Coverage On: Overweight | 52 | 39.84 | 30.52% | 1 | Jul 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 130 | 116.33 | 11.75% | 1 | Jul 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 110 130 | 185.53 | -29.93% | 3 | May 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 72 78 | n/a | n/a | 5 | May 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 6 4 | n/a | n/a | 2 | Apr 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | n/a | n/a | n/a | 3 | Jan 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 60 | n/a | n/a | 1 | Dec 18, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 5 | n/a | n/a | 1 | Dec 18, 2019 |